GFAP and diabetic neuropathy: Consistent with previous reports in models of diabetic neuropathy [11, 12, 36, 59], spinal GFAP immunofluorescence was significantly decreased in both the dorsal and the ventral horns of the spinal cord by day 50 in the HFD/STZ model.